nodes	percent_of_prediction	percent_of_DWPC	metapath
Pargyline—MAOB—prostate gland—urinary bladder cancer	0.071	0.118	CbGeAlD
Pargyline—MAOA—prostate gland—urinary bladder cancer	0.0606	0.101	CbGeAlD
Pargyline—MAOB—seminal vesicle—urinary bladder cancer	0.0601	0.1	CbGeAlD
Pargyline—MAOA—seminal vesicle—urinary bladder cancer	0.0513	0.0855	CbGeAlD
Pargyline—MAOB—renal system—urinary bladder cancer	0.0484	0.0807	CbGeAlD
Pargyline—MAOB—urethra—urinary bladder cancer	0.0476	0.0793	CbGeAlD
Pargyline—Benzphetamine—POR—urinary bladder cancer	0.0447	1	CrCbGaD
Pargyline—MAOA—renal system—urinary bladder cancer	0.0413	0.0689	CbGeAlD
Pargyline—MAOA—urethra—urinary bladder cancer	0.0406	0.0677	CbGeAlD
Pargyline—MAOB—Dopamine metabolism—NQO1—urinary bladder cancer	0.0398	0.112	CbGpPWpGaD
Pargyline—MAOB—female reproductive system—urinary bladder cancer	0.0388	0.0647	CbGeAlD
Pargyline—MAOB—vagina—urinary bladder cancer	0.0351	0.0585	CbGeAlD
Pargyline—MAOA—female reproductive system—urinary bladder cancer	0.0331	0.0552	CbGeAlD
Pargyline—MAOA—vagina—urinary bladder cancer	0.0299	0.0499	CbGeAlD
Pargyline—MAOA—Dopamine metabolism—NQO1—urinary bladder cancer	0.0249	0.0702	CbGpPWpGaD
Pargyline—MAOB—lymph node—urinary bladder cancer	0.0227	0.0378	CbGeAlD
Pargyline—MAOB—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.0221	0.0622	CbGpPWpGaD
Pargyline—MAOA—lymph node—urinary bladder cancer	0.0194	0.0323	CbGeAlD
Pargyline—MAOB—Biological oxidations—GSTZ1—urinary bladder cancer	0.015	0.0423	CbGpPWpGaD
Pargyline—MAOB—Biological oxidations—GSTO2—urinary bladder cancer	0.0143	0.0401	CbGpPWpGaD
Pargyline—MAOB—Biological oxidations—NAT1—urinary bladder cancer	0.0143	0.0401	CbGpPWpGaD
Pargyline—MAOA—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.0139	0.039	CbGpPWpGaD
Pargyline—MAOB—Biological oxidations—UGT2B7—urinary bladder cancer	0.013	0.0367	CbGpPWpGaD
Pargyline—MAOA—Oxidative Stress—NQO1—urinary bladder cancer	0.0128	0.0359	CbGpPWpGaD
Pargyline—MAOB—Biological oxidations—CYP4B1—urinary bladder cancer	0.0117	0.033	CbGpPWpGaD
Pargyline—MAOA—Oxidative Stress—SOD2—urinary bladder cancer	0.00983	0.0277	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—GSTZ1—urinary bladder cancer	0.00944	0.0266	CbGpPWpGaD
Pargyline—MAOA—Oxidative Stress—GPX1—urinary bladder cancer	0.00938	0.0264	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—GSTO2—urinary bladder cancer	0.00895	0.0252	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—NAT1—urinary bladder cancer	0.00895	0.0252	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—UGT2B7—urinary bladder cancer	0.00819	0.023	CbGpPWpGaD
Pargyline—MAOB—Biological oxidations—NAT2—urinary bladder cancer	0.00782	0.022	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—CYP4B1—urinary bladder cancer	0.00737	0.0207	CbGpPWpGaD
Pargyline—MAOB—Alpha-synuclein signaling—SRC—urinary bladder cancer	0.00693	0.0195	CbGpPWpGaD
Pargyline—MAOB—Biological oxidations—HPGDS—urinary bladder cancer	0.00625	0.0176	CbGpPWpGaD
Pargyline—MAOB—Biological oxidations—GSTT1—urinary bladder cancer	0.00606	0.017	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—NAT2—urinary bladder cancer	0.0049	0.0138	CbGpPWpGaD
Pargyline—MAOB—Biological oxidations—GSTP1—urinary bladder cancer	0.0042	0.0118	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—HPGDS—urinary bladder cancer	0.00392	0.011	CbGpPWpGaD
Pargyline—MAOB—Biological oxidations—GSTM1—urinary bladder cancer	0.00386	0.0109	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—GSTT1—urinary bladder cancer	0.0038	0.0107	CbGpPWpGaD
Pargyline—MAOA—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00339	0.00954	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—GSTP1—urinary bladder cancer	0.00264	0.00741	CbGpPWpGaD
Pargyline—MAOB—Metabolism—GSTZ1—urinary bladder cancer	0.00257	0.00724	CbGpPWpGaD
Pargyline—MAOB—Metabolism—GSTO2—urinary bladder cancer	0.00244	0.00686	CbGpPWpGaD
Pargyline—MAOB—Metabolism—NAT1—urinary bladder cancer	0.00244	0.00686	CbGpPWpGaD
Pargyline—MAOA—Biological oxidations—GSTM1—urinary bladder cancer	0.00242	0.00681	CbGpPWpGaD
Pargyline—MAOB—Metabolism—UGT2B7—urinary bladder cancer	0.00223	0.00628	CbGpPWpGaD
Pargyline—MAOB—Metabolism—CYP4B1—urinary bladder cancer	0.00201	0.00565	CbGpPWpGaD
Pargyline—MAOB—Metabolism—SLC19A1—urinary bladder cancer	0.0019	0.00534	CbGpPWpGaD
Pargyline—MAOB—Metabolism—PRSS3—urinary bladder cancer	0.00185	0.0052	CbGpPWpGaD
Pargyline—MAOA—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.0018	0.00507	CbGpPWpGaD
Pargyline—MAOA—Metabolism—GSTZ1—urinary bladder cancer	0.00161	0.00454	CbGpPWpGaD
Pargyline—MAOA—Metabolism—GSTO2—urinary bladder cancer	0.00153	0.00431	CbGpPWpGaD
Pargyline—MAOA—Metabolism—NAT1—urinary bladder cancer	0.00153	0.00431	CbGpPWpGaD
Pargyline—MAOB—Metabolism—TYMP—urinary bladder cancer	0.00148	0.00416	CbGpPWpGaD
Pargyline—MAOA—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.00143	0.00403	CbGpPWpGaD
Pargyline—MAOA—Metabolism—UGT2B7—urinary bladder cancer	0.0014	0.00394	CbGpPWpGaD
Pargyline—MAOB—Metabolism—NAT2—urinary bladder cancer	0.00134	0.00376	CbGpPWpGaD
Pargyline—MAOA—Metabolism—CYP4B1—urinary bladder cancer	0.00126	0.00355	CbGpPWpGaD
Pargyline—MAOA—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.00123	0.00345	CbGpPWpGaD
Pargyline—MAOA—Metabolism—SLC19A1—urinary bladder cancer	0.00119	0.00335	CbGpPWpGaD
Pargyline—MAOA—Metabolism—PRSS3—urinary bladder cancer	0.00116	0.00326	CbGpPWpGaD
Pargyline—MAOB—Metabolism—RRM2—urinary bladder cancer	0.00115	0.00325	CbGpPWpGaD
Pargyline—MAOB—Metabolism—ENO2—urinary bladder cancer	0.00107	0.00301	CbGpPWpGaD
Pargyline—MAOB—Metabolism—HPGDS—urinary bladder cancer	0.00107	0.00301	CbGpPWpGaD
Pargyline—MAOB—Metabolism—GSTT1—urinary bladder cancer	0.00104	0.00292	CbGpPWpGaD
Pargyline—MAOA—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000997	0.0028	CbGpPWpGaD
Pargyline—MAOA—Metabolism—TYMP—urinary bladder cancer	0.000927	0.00261	CbGpPWpGaD
Pargyline—MAOB—Metabolism—NQO1—urinary bladder cancer	0.000861	0.00242	CbGpPWpGaD
Pargyline—MAOA—Metabolism—NAT2—urinary bladder cancer	0.000839	0.00236	CbGpPWpGaD
Pargyline—MAOA—Metabolism—RRM2—urinary bladder cancer	0.000724	0.00204	CbGpPWpGaD
Pargyline—MAOB—Metabolism—GSTP1—urinary bladder cancer	0.000718	0.00202	CbGpPWpGaD
Pargyline—MAOA—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000689	0.00194	CbGpPWpGaD
Pargyline—MAOA—Metabolism—ENO2—urinary bladder cancer	0.000671	0.00189	CbGpPWpGaD
Pargyline—MAOA—Metabolism—HPGDS—urinary bladder cancer	0.000671	0.00189	CbGpPWpGaD
Pargyline—MAOB—Metabolism—TYMS—urinary bladder cancer	0.000668	0.00188	CbGpPWpGaD
Pargyline—MAOB—Metabolism—GSTM1—urinary bladder cancer	0.00066	0.00186	CbGpPWpGaD
Pargyline—MAOB—Metabolism—NCOR1—urinary bladder cancer	0.00066	0.00186	CbGpPWpGaD
Pargyline—MAOA—Metabolism—GSTT1—urinary bladder cancer	0.00065	0.00183	CbGpPWpGaD
Pargyline—MAOB—Metabolism—GPX1—urinary bladder cancer	0.000632	0.00178	CbGpPWpGaD
Pargyline—MAOB—Metabolism—ERCC2—urinary bladder cancer	0.000621	0.00175	CbGpPWpGaD
Pargyline—MAOB—Metabolism—MTHFR—urinary bladder cancer	0.000583	0.00164	CbGpPWpGaD
Pargyline—MAOA—Metabolism—NQO1—urinary bladder cancer	0.00054	0.00152	CbGpPWpGaD
Pargyline—MAOA—Neuronal System—HRAS—urinary bladder cancer	0.000528	0.00148	CbGpPWpGaD
Pargyline—MAOB—Metabolism—PPARG—urinary bladder cancer	0.000473	0.00133	CbGpPWpGaD
Pargyline—MAOB—Metabolism—CREBBP—urinary bladder cancer	0.000455	0.00128	CbGpPWpGaD
Pargyline—MAOA—Metabolism—GSTP1—urinary bladder cancer	0.000451	0.00127	CbGpPWpGaD
Pargyline—MAOA—Metabolism—TYMS—urinary bladder cancer	0.000419	0.00118	CbGpPWpGaD
Pargyline—MAOA—Metabolism—GSTM1—urinary bladder cancer	0.000414	0.00117	CbGpPWpGaD
Pargyline—MAOA—Metabolism—NCOR1—urinary bladder cancer	0.000414	0.00117	CbGpPWpGaD
Pargyline—MAOA—Metabolism—GPX1—urinary bladder cancer	0.000397	0.00112	CbGpPWpGaD
Pargyline—MAOA—Metabolism—ERCC2—urinary bladder cancer	0.000389	0.0011	CbGpPWpGaD
Pargyline—MAOB—Metabolism—PTGS2—urinary bladder cancer	0.000372	0.00105	CbGpPWpGaD
Pargyline—MAOA—Metabolism—MTHFR—urinary bladder cancer	0.000366	0.00103	CbGpPWpGaD
Pargyline—MAOB—Metabolism—PTEN—urinary bladder cancer	0.000325	0.000913	CbGpPWpGaD
Pargyline—MAOB—Metabolism—EP300—urinary bladder cancer	0.00031	0.000871	CbGpPWpGaD
Pargyline—MAOA—Metabolism—PPARG—urinary bladder cancer	0.000297	0.000835	CbGpPWpGaD
Pargyline—MAOA—Metabolism—CREBBP—urinary bladder cancer	0.000285	0.000802	CbGpPWpGaD
Pargyline—MAOA—Metabolism—PTGS2—urinary bladder cancer	0.000234	0.000657	CbGpPWpGaD
Pargyline—MAOA—Metabolism—PTEN—urinary bladder cancer	0.000204	0.000573	CbGpPWpGaD
Pargyline—MAOA—Metabolism—EP300—urinary bladder cancer	0.000194	0.000546	CbGpPWpGaD
